Aduhelm is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Biogen Inc.. The primary component is Aducanumab.
Product ID | 64406-102_389fccbc-5f19-4f85-bd4c-e6160a45b242 |
NDC | 64406-102 |
Product Type | Human Prescription Drug |
Proprietary Name | Aduhelm |
Generic Name | Aducanumab |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-06-07 |
Marketing Category | BLA / |
Application Number | BLA761178 |
Labeler Name | Biogen Inc. |
Substance Name | ADUCANUMAB |
Active Ingredient Strength | 100 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-06-07 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
64406-101 | Aduhelm | Aducanumab |
64406-102 | Aduhelm | Aducanumab |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ADUHELM 90709506 not registered Live/Pending |
Biogen MA Inc. 2021-05-13 |
ADUHELM 88841987 not registered Live/Pending |
Biogen MA Inc. 2020-03-20 |
ADUHELM 87840337 not registered Live/Pending |
Biogen MA, Inc. 2018-03-19 |